US Patent Issued to Vantive US Healthcare, Vantive Health on June 9 for "Therapy prediction and optimization for renal failure blood therapy" (Illinois Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,020, issued on June 9, was assigned to Vantive US Healthcare LLC (Deerfield, Ill.) and Vantive Health GMBH (Glattpark, Switzerland).

"Therapy prediction and optimization for renal failure blood therapy" was invented by Alp Akonur (Evanston, Ill.), John Kenneth Leypoldt (Libertyville, Ill.), Ying-Cheng Lo (Green Oaks, Ill.) and Baris Ugur Agar (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "A renal failure blood therapy system includes a memory device storing a therapy target for a patient. The system also includes a processor configured to receive the therapy target for the patient, receive a desired solute concentration for the patient, and ...